Skip to main content
padlock icon - secure page this page is secure

Effective salvage therapy for high‐risk relapsed or refractory acute myeloid leukaemia with cisplatin in combination with high‐dose cytarabine and etoposide

Buy Article:

$59.00 + tax (Refund Policy)

This study aimed at evaluating the efficacy and toxicity of the combination regimen of high‐dose cytarabine, etoposide and cisplatin (HAEP) in adult patients with high‐risk relapsed or refractory acute myeloid leukaemia (AML).
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: acute myeloid leukaemia; cisplatin; cytarabine; etoposide; salvage

Document Type: Research Article

Publication date: June 1, 2014

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more